DK1532139T3 - Totalsyntese af myriaporoner - Google Patents
Totalsyntese af myriaporonerInfo
- Publication number
- DK1532139T3 DK1532139T3 DK03771210T DK03771210T DK1532139T3 DK 1532139 T3 DK1532139 T3 DK 1532139T3 DK 03771210 T DK03771210 T DK 03771210T DK 03771210 T DK03771210 T DK 03771210T DK 1532139 T3 DK1532139 T3 DK 1532139T3
- Authority
- DK
- Denmark
- Prior art keywords
- substituted
- unsubstituted
- group
- aralkyl
- aryl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
- C07D303/32—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by aldehydo- or ketonic radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/08—Bridged systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines Containing Plant Substances (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Epoxy Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0217638.6A GB0217638D0 (en) | 2002-07-30 | 2002-07-30 | Total synthesis of myriaporones |
PCT/GB2003/003327 WO2004011458A1 (en) | 2002-07-30 | 2003-07-30 | Total synthesis of myriaporones |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1532139T3 true DK1532139T3 (da) | 2007-10-15 |
Family
ID=9941374
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK03771210T DK1532139T3 (da) | 2002-07-30 | 2003-07-30 | Totalsyntese af myriaporoner |
Country Status (20)
Country | Link |
---|---|
US (1) | US7521478B2 (da) |
EP (1) | EP1532139B1 (da) |
JP (1) | JP2006504659A (da) |
KR (1) | KR20050053599A (da) |
CN (1) | CN100390167C (da) |
AT (1) | ATE364603T1 (da) |
AU (1) | AU2003248984A1 (da) |
CA (1) | CA2494532A1 (da) |
DE (1) | DE60314426T2 (da) |
DK (1) | DK1532139T3 (da) |
ES (1) | ES2289337T3 (da) |
GB (1) | GB0217638D0 (da) |
IL (1) | IL166484A0 (da) |
MX (1) | MXPA05001176A (da) |
NO (1) | NO20051037L (da) |
NZ (1) | NZ537678A (da) |
PT (1) | PT1532139E (da) |
RU (1) | RU2328492C2 (da) |
SI (1) | SI1532139T1 (da) |
WO (1) | WO2004011458A1 (da) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JOP20190254A1 (ar) | 2017-04-27 | 2019-10-27 | Pharma Mar Sa | مركبات مضادة للأورام |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5514708A (en) | 1994-02-18 | 1996-05-07 | Pharmamar, S.A. | Cytotoxic metabolites from Myriapora truncata |
-
2002
- 2002-07-30 GB GBGB0217638.6A patent/GB0217638D0/en not_active Ceased
-
2003
- 2003-07-30 ES ES03771210T patent/ES2289337T3/es not_active Expired - Lifetime
- 2003-07-30 EP EP03771210A patent/EP1532139B1/en not_active Expired - Lifetime
- 2003-07-30 PT PT03771210T patent/PT1532139E/pt unknown
- 2003-07-30 US US10/523,172 patent/US7521478B2/en not_active Expired - Fee Related
- 2003-07-30 CA CA002494532A patent/CA2494532A1/en not_active Abandoned
- 2003-07-30 JP JP2004523987A patent/JP2006504659A/ja active Pending
- 2003-07-30 MX MXPA05001176A patent/MXPA05001176A/es active IP Right Grant
- 2003-07-30 SI SI200330909T patent/SI1532139T1/sl unknown
- 2003-07-30 DE DE60314426T patent/DE60314426T2/de not_active Expired - Fee Related
- 2003-07-30 AU AU2003248984A patent/AU2003248984A1/en not_active Abandoned
- 2003-07-30 WO PCT/GB2003/003327 patent/WO2004011458A1/en active IP Right Grant
- 2003-07-30 RU RU2005105329/04A patent/RU2328492C2/ru not_active IP Right Cessation
- 2003-07-30 KR KR1020057001661A patent/KR20050053599A/ko not_active Application Discontinuation
- 2003-07-30 AT AT03771210T patent/ATE364603T1/de not_active IP Right Cessation
- 2003-07-30 NZ NZ537678A patent/NZ537678A/en unknown
- 2003-07-30 DK DK03771210T patent/DK1532139T3/da active
- 2003-07-30 CN CNB038233142A patent/CN100390167C/zh not_active Expired - Fee Related
-
2005
- 2005-01-25 IL IL16648405A patent/IL166484A0/xx unknown
- 2005-02-25 NO NO20051037A patent/NO20051037L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NZ537678A (en) | 2006-11-30 |
KR20050053599A (ko) | 2005-06-08 |
EP1532139A1 (en) | 2005-05-25 |
RU2328492C2 (ru) | 2008-07-10 |
EP1532139B1 (en) | 2007-06-13 |
US20060084819A1 (en) | 2006-04-20 |
IL166484A0 (en) | 2006-01-15 |
US7521478B2 (en) | 2009-04-21 |
GB0217638D0 (en) | 2002-09-11 |
ATE364603T1 (de) | 2007-07-15 |
WO2004011458A1 (en) | 2004-02-05 |
ES2289337T3 (es) | 2008-02-01 |
US20080269511A2 (en) | 2008-10-30 |
RU2005105329A (ru) | 2005-08-27 |
CA2494532A1 (en) | 2004-02-05 |
AU2003248984A1 (en) | 2004-02-16 |
DE60314426D1 (de) | 2007-07-26 |
US20080103320A2 (en) | 2008-05-01 |
SI1532139T1 (sl) | 2007-10-31 |
JP2006504659A (ja) | 2006-02-09 |
DE60314426T2 (de) | 2008-02-14 |
NO20051037L (no) | 2005-04-13 |
MXPA05001176A (es) | 2005-09-12 |
CN1684956A (zh) | 2005-10-19 |
PT1532139E (pt) | 2007-09-20 |
CN100390167C (zh) | 2008-05-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1117297T3 (da) | Syntetiske analoger af ecteinascidin-743 | |
NO20012617D0 (no) | Kinolin- og kinzolinderivater | |
CY1109283T1 (el) | Παραγωγα βαριολινης ως αντικαρκινικα μεσα | |
DK0535231T3 (da) | Pyrimidinnucleosid-derivater | |
CY1113359T1 (el) | Αντι-νεοπλασιακα παραγωγα του et-743 | |
DK1847534T3 (da) | Thiadiazolin-derivater til behandling af kræft | |
NO20051037L (no) | Totalsyntese av myriaporoner | |
NO20040113L (no) | Variolinderivater og deres anvendelse som antitumormidler | |
ATE552003T1 (de) | Chinoxalinderivate | |
DE60116855D1 (de) | Oxy- und aminosubstituierte tetrahydrofurylderivate mit antitumoraktivität |